| 20185899 |
Economou M, Printza N, Teli A, Tzimouli V, Tsatra I, Papachristou F, Athanassiou-Metaxa M: Renal Dysfunction in Patients with Beta-Thalassemia Major Receiving Iron Chelation Therapy either with Deferoxamine and Deferiprone or with Deferasirox. Acta Haematol. 2010;123(3):148-152. Epub 2010 Feb 24.
In addition to conventional renal biochemistries, creatinine clearance, estimated glomerular filtration rate, serum cystatin C (Cys C), fractional excretion of sodium, tubular phosphorus reabsorption and urine calcium, protein, beta (2)-microglobulin (beta (2)-MG) and glucose levels were measured. |
6(0,0,1,1) |
Details |
| 19295502 |
Muntner P, Vupputuri S, Coresh J, Uribarri J, Fox CS: Metabolic abnormalities are present in adults with elevated serum cystatin C. Kidney Int. 2009 Jul;76(1):81-8. Epub 2009 Mar 18.
In the absence of stage 3 or 4 CKD, patients with elevated serum cystatin C had a higher prevalence of low hemoglobin and elevated uric acid, homocysteine, phosphorus, fibrinogen, and C-reactive protein than patients with a normal serum cystatin C. |
9(0,0,1,4) |
Details |